Inhibitory effect of albumin-derived advanced glycosylation products on PMA-induced superoxide anion production by rat macrophages

Life Sciences

Volumn 60, Issue 25, 1997, Pages 2279-2289

  Ramírez, Remedies ^a   Bedoya, Francisco J ^a   Dolores Chiara, M ^a   Sobrino, Francisco ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Albumin derived advance glycosylation products; Diabetes; Macrophages; Superoxide anion

Indexed keywords

AMINOGUANIDINE; CYTOCHROME C; PHORBOL 13 ACETATE 12 MYRISTATE; SUPEROXIDE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; IN VITRO STUDY; INFECTIOUS COMPLICATION; MACROPHAGE FUNCTION; MALE; NONHUMAN; PERITONEUM MACROPHAGE; PROTEIN GLYCOSYLATION; RAT; RESPIRATORY BURST; STREPTOZOCIN DIABETES;

ANIMALS; ANIONS; CATTLE; CYTOCHROME C GROUP; DIABETES MELLITUS, EXPERIMENTAL; GLYCOSYLATION END PRODUCTS, ADVANCED; MACROPHAGES, PERITONEAL; MALE; OXIDATION-REDUCTION; RATS; RATS, WISTAR; RESPIRATORY BURST; SERUM ALBUMIN, BOVINE; SUPEROXIDES; TETRADECANOYLPHORBOL ACETATE;

EID: 0343052880     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00283-X     Document Type: Article

References (33)

1. S.V. SHAH, J.D. WALLIN, and S.D. EILEN, . Clin. Endocrinol. Metab. 52 402-409 (1983).
2. V. MOHSENIN, and J. LATEFPOUR, . Appl. Physiol. 68 2384-2390 (1990).
3. C.P. NIELSON, and D.A. fflNDSON, Diabetes 28 1031-1035 (1989).
4. F.G. NJOROGE, and V.M. MONNIER, Prag. Clin. Biol. Res. 304 85-197 (1989).
5. R. BUCALA, and A. CERAMI, . Pharmacol. 22 1-34 (1992).
6. V.M. MONNIER, R.R. KOHN, and A. CERAMI, . Natl. Acad. Sci. U.S.A. 81 583-587 (1984).
7. V.M. MONNIER, . Gerentol. 45 B105-B111 (1990).
8. M. BROWNLEE, S. PONGOR, and A. CERAMI, . Exp. Med. 158 1739-1744 (1983).
9. M. BROWNLEE, H. VLASSARA, and A. CERAMI, Diabetes 24 938-941 (1985).
10. M. BROWNLEE, A. CERAMI, and H. VLASSARA, . Engl. J. Med. 318 1315-1321 (1988).
11. H. VLASSARA, M. BROWNLEE, and A. CERAMI, . Natl. Acad. Sci. U.S.A. 82 5588-5592 (1985).
12. H. VLASSARA, M. BROWNLEE, and A. CERAMI, . Exp. Med. 164 1301-1309 (1986).
13. S. RADOFF, A. CERAMI, and H. VLASSARA, Diabetes 22 1510-1518 (1990).
14. H. VLASSARA, M. BROWNLEE, K.R. MANOGUE, C.A. DINARELLO, and A. PASAGIAN, Science 240 1546-1548 (1988).
15. M. KIRSTEIN, J. BRETT, S. RADOFF, S. OGAWA, and H. VLASSARA, . Natl. Acad. Sci. U.S.A. 82 9010-9014 (1990).
16. M. KIRSTEIN, C. ASTON, R. HINTZ, and H. VLASSARA, . Clin. Invest. 2Q 439-446 (1992).
17. N.E. CAMERON, M.A. COTTER, K. DINES, and A. LOVE, Diabetologia 25 946-950 (1992).
18. D.E. MOSIER, Methods Enzymol. 108 294-297 (1984).
19. B.M. BABIOR, R.S. KIPNES, and J.T. CURNETTE, . Clin. Invest. 52 741-744 (1973).
20. O.H. LOWRY, .J. ROSEBROUGH, A.L. FARR, and R.J. RANDALL, . Biol. Chem. 193 265-275(1951).
21. B.M. BABIOR, Blood 64 959-966 (1984).
22. M. BROWNLEE, H. VLASSARA, and A. CERAMI, . Intern. Med. 101 527-537 (1984).
23. M. BROWNLEE, and A. CERAMI, u. Rev. Biochem. 50 385-432 (1981).
24. M.E. HOLT, M.T.E. RYALL, and A.K. CAMPBELL, B. J. Exp. Path. 5 231-241 (1984).
25. M. BROWNLEE, H. VLASSARA, T. KOONEY, P. ULRICH, and A. CERAMI, Science 232 1629-1632 (1986).
26. K. NICHOLLS, and T.E. MANDEL, Lab. Invest. 60 486-493 (1989).
27. J.R. WILLIAMSON, K. CHANG, Y. IDO, E. OSTROW, W. ALLISON, . HARLOW, and R.G. TILTON, Diabetes Metab. 16 369-370 (1990).
28. T. SOULIS-LIPAROTA, M. COOPER, D. PAPAZOGLOU, B. CLARKE, and G. JERUMS, Diabetes 40 1328-1334 (1991).
29. M. KIHARA, J.D. SCHMELZER, J.F. PODUSLO, G.L. CURRAN, K.K. NICKANDER, and P.A. LOW, . Natl. Acad. Sci. U.S.A. 88 6107-6111 (1991).
30. K. KUMARI, S. UMAR, V. BANSAL, and M.K. SAHIB, Diabetes 40 1079-1084 (1991).
31. R.G. TILTON, K. CHANG, K.S. HASAN, S.R. SMITH, J.M. PETRASH, T.P. MISKO, W.M.MOORE, M.G. CURRIE, I.A. CORBERTT, M.L. MCDANIEL, and J.R. WILLIAMSON, Diabetes 42 221-232 (1993).
32. T. MATSUBARA, and M. ZIFF, . Immunol. 122 3295-3298 (1986).
33. S.H. PINCUS, E.A. WHITCOMB, and C.A. DINARELLO, . Immunol. 137 3509-3514 (1986).